Home-Based FeNO Monitoring with the Vivatmo me Device Reveals Type 2 Inflammatory Patterns of Patients with Asthma at Different Treatment Steps: The FeNO@Home Study

This is a Human Clinical Trial study (also classified as: Pre-Registered Trial).

December 10, 2025Pulmonary TherapyOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study aims to assess how home-based FeNO monitoring can reflect inflammatory patterns in asthma patients across different treatment stages.
Conducted a clinical trial on home-based monitoring using the Vivatmo device.
Monitored FeNO levels in patients with asthma at various treatment steps.
Data collected focused on identifying type 2 inflammatory patterns.
Found distinct type 2 inflammatory patterns in asthma patients.
Revealed varying FeNO levels corresponding to different treatment steps.
Data suggests home monitoring can improve asthma management.

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

Clinical trial shows FeNO monitoring detects inflammatory patterns in patients, suggesting personalized asthma management.

German Clinical Trial Register (DRKS) DRKS00029118, registered July 1, 2022.

No takes yet. Share an insight, caveat, or question.

Beeh et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share